Literature DB >> 18247384

Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.

Patrick Couvreur1, L Harivardhan Reddy, Stéphanie Mangenot, Jacques H Poupaert, Didier Desmaële, Sinda Lepêtre-Mouelhi, Barbara Pili, Claudie Bourgaux, H Amenitsch, Michel Ollivon.   

Abstract

In this study, the dynamically folded conformation of squalene (SQ) is taken advantage of to link this natural compound to the anticancer nucleoside analogue gemcitabine (gem) in order to achieve the spontaneous formation of nanoassemblies (SQgem) in water. Cryogenic transmission electron microscopy examination reveals particles (104 nm) with a hexagonal or multifaceted shape that display an internal structure made of reticular planes, each particle being surrounded by an external shell. X-ray diffraction evidences the hexagonal molecular packing of SQgem, resulting from the stacking of direct or inverse cylinders. The respective volumes of the gem and SQ molecules as well as molecular modeling of SQgem suggest the stacking of inverse hexagonal phases, in which the central aqueous core, consisting of water and gem molecules, is surrounded by SQ moieties. These SQgem nanoassemblies also exhibit impressively greater anticancer activity than gem against a solid subcutaneously grafted tumor, following intravenous administration. To our knowledge, this is the first demonstration of hexagonal phase organization with a SQ derivative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247384     DOI: 10.1002/smll.200700731

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  16 in total

Review 1.  Lipid-Drug Conjugate for Enhancing Drug Delivery.

Authors:  Danielle Irby; Chengan Du; Feng Li
Journal:  Mol Pharm       Date:  2017-01-24       Impact factor: 4.939

Review 2.  Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.

Authors:  Sifei Han; Lianghe Mei; Tim Quach; Chris Porter; Natalie Trevaskis
Journal:  Pharm Res       Date:  2021-08-31       Impact factor: 4.200

3.  PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.

Authors:  Alice Gaudin; Eric Song; Amanda R King; Jennifer K Saucier-Sawyer; Ranjit Bindra; Didier Desmaële; Patrick Couvreur; W Mark Saltzman
Journal:  Biomaterials       Date:  2016-08-04       Impact factor: 12.479

Review 4.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

5.  Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan.

Authors:  Sergio Cafaggi; Eleonora Russo; Rossana Stefani; Brunella Parodi; Gabriele Caviglioli; Greta Sillo; Angela Bisio; Cinzia Aiello; Maurizio Viale
Journal:  Invest New Drugs       Date:  2009-12-29       Impact factor: 3.850

6.  Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.

Authors:  Donato Cosco; Flavio Rocco; Maurizio Ceruti; Margherita Vono; Massimo Fresta; Donatella Paolino
Journal:  Int J Nanomedicine       Date:  2012-05-23

Review 7.  Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices.

Authors:  Vanessa Allain; Claudie Bourgaux; Patrick Couvreur
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

8.  Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.

Authors:  Carlos Rodríguez-Nogales; Didier Desmaële; Víctor Sebastián; Patrick Couvreur; María J Blanco-Prieto
Journal:  ChemMedChem       Date:  2021-10-22       Impact factor: 3.540

9.  Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes.

Authors:  Rami Alzhrani; Hashem O Alsaab; Kushal Vanamal; Ketki Bhise; Katyayani Tatiparti; Ayatakshi Barari; Samaresh Sau; Arun K Iyer
Journal:  Adv Ther (Weinh)       Date:  2021-04-24

10.  Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers.

Authors:  Caterina Longo; Alexis Patanarut; Tony George; Barney Bishop; Weidong Zhou; Claudia Fredolini; Mark M Ross; Virginia Espina; Giovanni Pellacani; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.